BEI Inactivated Vaccine Induces Innate and Adaptive Responses and Elicits Partial Protection upon Reassortant Betanodavirus Infection in Senegalese Sole

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Microbioloxía e Parasitoloxíagl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Instituto de Acuicultura
dc.contributor.authorValero Cuesta, Yulema
dc.contributor.authorOlveira Hermida, José Gabriel
dc.contributor.authorLópez Vázquez, Carmen
dc.contributor.authorPereira Dopazo, Carlos
dc.contributor.authorBandín Matos, Isabel
dc.date.accessioned2021-06-04T12:27:27Z
dc.date.available2021-06-04T12:27:27Z
dc.date.issued2021
dc.description.abstractNervous necrosis virus (NNV), the causative agent of viral encephalopathy and retinopathy (VER), is one of the most threatening viruses affecting marine and freshwater fish species worldwide. Senegalese sole is a promising fish species in Mediterranean aquaculture but also highly susceptible to NNV and VER outbreaks, that puts its farming at risk. The development of vaccines for aquaculture is one of best tools to prevent viral spread and sudden outbreaks, and virus inactivation is the simplest and most cost-effective method available. In this work, we have designed two inactivated vaccines based on the use of formalin or binary ethylenimine (BEI) to inactivate a reassortant NNV strain. After vaccination, the BEI-inactivated vaccine triggered the production of specific IgM-NNV antibodies and stimulated innate and adaptive immune responses at transcriptional level (rtp3, mx, mhcii and tcrb coding genes). Moreover, it partially improved survival after an NNV in vivo challenge, reducing the mid-term viral load and avoiding the down-regulation of immune response post-challenge. On the other hand, the formalin-inactivated vaccine improved the survival of fish upon infection without inducing the production of IgM-NNV antibodies and only stimulating the expression of herc4 and mhcii genes (in head-kidney and brain, respectively) during the vaccination period; this suggests that other immune-related pathways may be involved in the partial protection provoked. Although these vaccines against NNV showed encouraging results, further studies are needed to improve sole protection and to fully understand the underlying immune mechanismgl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was supported by grant RTI2018-094687-B-C21 from MICIU (Spain) co-funded by FEDERgl
dc.identifier.citationVaccines 2021, 9(5), 458; https://doi.org/10.3390/vaccines9050458gl
dc.identifier.doi10.3390/vaccines9050458
dc.identifier.essn2076-393X
dc.identifier.urihttp://hdl.handle.net/10347/26398
dc.language.isoenggl
dc.publisherMDPIgl
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/ RTI2018-094687-B-C21/ES/VACUNAS DE BETANODAVIRUS PARA LENGUADO Y LUBINA: DESARROLLO Y VALIDACION DE VACUNAS ATENUADAS, INACTIVADAS Y DE DNA Y ESTUDIO DE LA RESPUESTA INMUNE EN LOS PECES VACUNADOS
dc.relation.publisherversionhttps://doi.org/10.3390/vaccines9050458gl
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)gl
dc.rightsAtribución 4.0 Internacional
dc.rights.accessRightsopen accessgl
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectSenegalese solegl
dc.subjectInactivated vaccinegl
dc.subjectBEIgl
dc.subjectFormalingl
dc.subjectNervous necrosis virusgl
dc.subjectImmune responsegl
dc.subjectAntibodiesgl
dc.subjectGene expressiongl
dc.titleBEI Inactivated Vaccine Induces Innate and Adaptive Responses and Elicits Partial Protection upon Reassortant Betanodavirus Infection in Senegalese Solegl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication597b57e6-596f-4ae2-92a8-96b4028fdace
relation.isAuthorOfPublicationd33c2dc0-6a21-4564-b407-42d0c2069984
relation.isAuthorOfPublication38f06b7a-de73-49cb-9e84-54d34ade5c2c
relation.isAuthorOfPublication.latestForDiscovery597b57e6-596f-4ae2-92a8-96b4028fdace

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021_vaccines_valero_bei.pdf
Size:
4.26 MB
Format:
Adobe Portable Document Format
Description: